PPCB
Price:
$0.99
Market Cap:
$865.63K
Propanc Biopharma, Inc. (PPCB) is an Australian biopharmaceutical firm dedicated to developing innovative treatments for various cancers, with a particular focus on pancreatic, ovarian, and colorectal malignancies. The company's leading therapeutic candidate, PRP, is a unique formulation currently in the preclinical stage of development. This product is designed to enhance the effectiveness of multiple enzymes that work together to combat cancer. Propanc Biopharma is also engaged in a collaborative research effort with the University of Jaén, initiating the POP1 joint drug discovery program. Founded in 2007, the entity was originally known as Propanc Health Group Corporation before officiall...[Read more]
Industry
Biotechnology
IPO Date
2012-11-12
Stock Exchange
NASDAQ
Ticker
PPCB
According to Propanc Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -148.23%. This represents a change of 283.33% compared to the average of -38.67% of the last 4 quarters.
The mean historical ROE of Propanc Biopharma, Inc. over the last ten years is 74.35%. The current -148.23% ROE has changed -299.37% with respect to the historical average. Over the past ten years (40 quarters), PPCB's ROE was at its highest in in the June 2016 quarter at 111.37%. The ROE was at its lowest in in the March 2025 quarter at -298.84%.
Average
74.35%
Median
96.08%
Minimum
-423.72%
Maximum
366.82%
Discovering the peaks and valleys of Propanc Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 228.18%
Maximum Annual ROE = 366.82%
Minimum Annual Increase = -979.33%
Minimum Annual ROE = -423.72%
| Year | ROE | Change |
|---|---|---|
| 2025 | -423.72% | -979.33% |
| 2024 | 48.19% | -43.55% |
| 2023 | 85.37% | -2.89% |
| 2022 | 87.91% | 33.10% |
| 2021 | 66.05% | -49.27% |
| 2020 | 130.20% | -2.74% |
| 2019 | 133.87% | 28.41% |
| 2018 | 104.25% | -27.89% |
| 2017 | 144.57% | -60.59% |
| 2016 | 366.82% | 228.18% |
The current ROE of Propanc Biopharma, Inc. (PPCB) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-96.72%
5-year avg
-27.24%
10-year avg
74.35%
Propanc Biopharma, Inc.’s ROE is less than Quest PharmaTech Inc. (21.70%), less than Gemina Laboratories Ltd. (62.39%), greater than Telescope Innovations Corp. (-101.95%), less than PreveCeutical Medical Inc. (23.09%), greater than Synairgen plc (-51.06%), less than EOM Pharmaceuticals Holdings, Inc. (127.66%), less than Cell Source, Inc. (22.48%), less than Zenith Capital Corp. (0%), greater than HOOKIPA Pharma Inc. (-54.85%), less than Sirona Biochem Corp. (221.45%),
| Company | ROE | Market cap |
|---|---|---|
| 21.70% | $3.38M | |
| 62.39% | $3.83M | |
| -101.95% | $23.80M | |
| 23.09% | $7.66M | |
| -51.06% | $110.27K | |
| 127.66% | $16.45M | |
| 22.48% | $37.08M | |
| 0% | $7.99M | |
| -54.85% | $14.40M | |
| 221.45% | $1.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Propanc Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Propanc Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Propanc Biopharma, Inc.'s ROE?
How is the ROE calculated for Propanc Biopharma, Inc. (PPCB)?
What is the highest ROE for Propanc Biopharma, Inc. (PPCB)?
What is the 3-year average ROE for Propanc Biopharma, Inc. (PPCB)?
What is the 5-year average ROE for Propanc Biopharma, Inc. (PPCB)?
How does the current ROE for Propanc Biopharma, Inc. (PPCB) compare to its historical average?